What's breaking now, across thousands of outlets.
(RTTNews) - Wednesday, Silexion Therapeutics (SLXN) said the first patient has been dosed in its global Phase 2/3 trial evaluating SIL204 in patients with locally advanced pancreatic cancer (LAPC).
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Patients at Jinnah Postgraduate Medical Center in Karachi can receive robot-assisted surgery, including complex cancer operations, free of charge. Nearly … Read More The post Jinnah Hospital to Reserve Free Robotic Surgery for Complex Operations appeared first on ProPakistani .
Dubai: For years, Lenilyn Arsega did not know she had been living with a congenital heart defect. It was only during a routine check-up while she was eight weeks pregnant that doctors discovered the condition setting the 38-year-old Filipina on a medical journey that ultimately led to specialised heart surgery in Dubai.
Moderna stock has rallied more than 200% since August, following positive Phase 3 trial results for a melanoma vaccine.
You may not know her name, but South African lawyer and bioethicist Kwanele Asante has spent two decades pushing health institutions — from Soweto to the United Nations – to listen to the people their…
A new study from the University of Missouri offers hope for those who are at significantly higher risk of developing Alzheimer's disease later in life.
An analysis of commercial claims for 106 physician-administered outpatient drugs suggests $101 of additional plan spending per member per year stemming from site-of-treatment pay differences.
